Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT07104331 |
| Title | SARC046: A Phase II Trial of Nab-Sirolimus in Patients With Progressing or Symptomatic Epithelioid Hemangioendothelioma |
| Recruitment | Not yet recruiting |
| Gender | both |
| Phase | Phase II |
| Variant Requirements | No |
| Sponsors | Sarcoma Alliance for Research through Collaboration |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Stanford University | Stanford | California | 94305 | United States | Details | |
| University of Colorado | Aurora | Colorado | 80203 | United States | Details | |
| Brigham and Women's Hospital | Boston | Massachusetts | 02115 | United States | Details | |
| Dana-Farber Cancer Institute | Boston | Massachusetts | 02215 | United States | Details | |
| Washington University St. Louis | St Louis | Missouri | 63130 | United States | Details | |
| Sloan Kettering Institute for Cancer Research | New York | New York | 10065 | United States | Details |